These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37549269)

  • 41. Transcriptomic Analysis of Histone Methyltransferase Setd7 Knockdown and Phenethyl Isothiocyanate in Human Prostate Cancer Cells.
    Wang C; Sargsyan D; Zhang C; Wu R; Yang Y; Kong AN
    Anticancer Res; 2018 Nov; 38(11):6069-6083. PubMed ID: 30396921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
    Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
    Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer.
    Helminen L; Huttunen J; Tulonen M; Aaltonen N; Niskanen EA; Palvimo JJ; Paakinaho V
    Nucleic Acids Res; 2024 Jan; 52(2):625-642. PubMed ID: 38015476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
    Zhang Y; Tong T
    Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
    Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
    Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
    Baca SC; Takeda DY; Seo JH; Hwang J; Ku SY; Arafeh R; Arnoff T; Agarwal S; Bell C; O'Connor E; Qiu X; Alaiwi SA; Corona RI; Fonseca MAS; Giambartolomei C; Cejas P; Lim K; He M; Sheahan A; Nassar A; Berchuck JE; Brown L; Nguyen HM; Coleman IM; Kaipainen A; De Sarkar N; Nelson PS; Morrissey C; Korthauer K; Pomerantz MM; Ellis L; Pasaniuc B; Lawrenson K; Kelly K; Zoubeidi A; Hahn WC; Beltran H; Long HW; Brown M; Corey E; Freedman ML
    Nat Commun; 2021 Mar; 12(1):1979. PubMed ID: 33785741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer.
    Cai L; Tsai YH; Wang P; Wang J; Li D; Fan H; Zhao Y; Bareja R; Lu R; Wilson EM; Sboner A; Whang YE; Zheng D; Parker JS; Earp HS; Wang GG
    Mol Cell; 2018 Oct; 72(2):341-354.e6. PubMed ID: 30270106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOXA1 regulates ribosomal RNA transcription in prostate cancer.
    Jia T; Liu C; Guo P; Xu Y; Wang W; Liu X; Wang S; Zhang X; Guo H
    Prostate; 2024 Jul; 84(10):967-976. PubMed ID: 38632701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
    Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
    Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
    Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
    Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.
    Cai C; He HH; Chen S; Coleman I; Wang H; Fang Z; Chen S; Nelson PS; Liu XS; Brown M; Balk SP
    Cancer Cell; 2011 Oct; 20(4):457-71. PubMed ID: 22014572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase.
    Ko S; Ahn J; Song CS; Kim S; Knapczyk-Stwora K; Chatterjee B
    Mol Endocrinol; 2011 Mar; 25(3):433-44. PubMed ID: 21273441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer.
    Takayama KI; Kosaka T; Suzuki T; Hongo H; Oya M; Fujimura T; Suzuki Y; Inoue S
    Nat Commun; 2021 Jun; 12(1):3766. PubMed ID: 34145268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crosstalk between lysine methylation and phosphorylation of ATG16L1 dictates the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes.
    Song H; Feng X; Zhang M; Jin X; Xu X; Wang L; Ding X; Luo Y; Lin F; Wu Q; Liang G; Yu T; Liu Q; Zhang Z
    Autophagy; 2018; 14(5):825-844. PubMed ID: 29634390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
    Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
    Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FOXA1 in prostate cancer.
    Dong HY; Ding L; Zhou TR; Yan T; Li J; Liang C
    Asian J Androl; 2023; 25(3):287-295. PubMed ID: 36018068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens.
    Yeh IJ; Song K; Wittmann BM; Bai X; Danielpour D; Montano MM
    Biochem J; 2014 Sep; 462(2):315-27. PubMed ID: 24844355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer.
    Singh R; Meng H; Shen T; Lumahan LEV; Nguyen S; Shen H; Dasgupta S; Qin L; Karri D; Zhu B; Yang F; Coarfa C; O'Malley BW; Yi P
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2218229120. PubMed ID: 37155905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.